Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingShares Repurchased
Ratios

Guardian Pharmacy Services (GRDN) Shares Outstanding (2024 - 2025)

Guardian Pharmacy Services (GRDN) has disclosed Shares Outstanding for 2 consecutive years, with $36.3 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding fell 32.97% to $36.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $36.3 million through Dec 2025, down 32.97% year-over-year, with the annual reading at $36.3 million for FY2025, 32.97% down from the prior year.
  • Shares Outstanding hit $36.3 million in Q4 2025 for Guardian Pharmacy Services, roughly flat from $36.3 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $54.1 million in Q4 2024 to a low of $9.2 million in Q3 2024.